BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28088687)

  • 1. Whole-Genome DNA Methylation Profiling Identifies Epigenetic Signatures of Uterine Carcinosarcoma.
    Li J; Xing X; Li D; Zhang B; Mutch DG; Hagemann IS; Wang T
    Neoplasia; 2017 Feb; 19(2):100-111. PubMed ID: 28088687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing inter-component heterogeneity of biphasic uterine carcinosarcomas.
    Liu Y; Weber Z; San Lucas FA; Deshpande A; Jakubek YA; Sulaiman R; Fagerness M; Flier N; Sulaiman J; Davis CM; Fowler J; Starks D; Rojas-Espaillat L; Lazar AJ; Davies GE; Ehli EA; Scheet P
    Gynecol Oncol; 2018 Nov; 151(2):243-249. PubMed ID: 30194005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Molecular Characterization of Uterine Carcinosarcoma.
    Cherniack AD; Shen H; Walter V; Stewart C; Murray BA; Bowlby R; Hu X; Ling S; Soslow RA; Broaddus RR; Zuna RE; Robertson G; Laird PW; Kucherlapati R; Mills GB; ; Weinstein JN; Zhang J; Akbani R; Levine DA
    Cancer Cell; 2017 Mar; 31(3):411-423. PubMed ID: 28292439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide DNA methylome variation in two genetically distinct chicken lines using MethylC-seq.
    Li J; Li R; Wang Y; Hu X; Zhao Y; Li L; Feng C; Gu X; Liang F; Lamont SJ; Hu S; Zhou H; Li N
    BMC Genomics; 2015 Oct; 16():851. PubMed ID: 26497311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer.
    Maxwell GL; Chandramouli GV; Dainty L; Litzi TJ; Berchuck A; Barrett JC; Risinger JI
    Clin Cancer Res; 2005 Jun; 11(11):4056-66. PubMed ID: 15930340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profiles of carcinosarcoma of the uterine corpus-are these similar to carcinoma or sarcoma?
    Chiyoda T; Tsuda H; Tanaka H; Kataoka F; Nomura H; Nishimura S; Takano M; Susumu N; Saya H; Aoki D
    Genes Chromosomes Cancer; 2012 Mar; 51(3):229-39. PubMed ID: 22072501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas.
    Le Gallo M; Rudd ML; Urick ME; Hansen NF; ; Merino MJ; Mutch DG; Goodfellow PJ; Mullikin JC; Bell DW
    Cancer; 2018 Jan; 124(1):65-73. PubMed ID: 28940304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas.
    Tseng JH; Bisogna M; Hoang LN; Olvera N; Rodriguez-Aguayo C; Lopez-Berestein G; Sood AK; Levine DA; Jelinic P
    Sci Rep; 2017 Jun; 7(1):3614. PubMed ID: 28620240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity.
    Matsuzaki S; Klar M; Matsuzaki S; Roman LD; Sood AK; Matsuo K
    Gynecol Oncol; 2021 Feb; 160(2):586-601. PubMed ID: 33183764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors.
    Wada H; Enomoto T; Fujita M; Yoshino K; Nakashima R; Kurachi H; Haba T; Wakasa K; Shroyer KR; Tsujimoto M; Hongyo T; Nomura T; Murata Y
    Cancer Res; 1997 Dec; 57(23):5379-85. PubMed ID: 9393763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
    Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
    Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperation of Sox4 with β-catenin/p300 complex in transcriptional regulation of the Slug gene during divergent sarcomatous differentiation in uterine carcinosarcoma.
    Inoue H; Takahashi H; Hashimura M; Eshima K; Akiya M; Matsumoto T; Saegusa M
    BMC Cancer; 2016 Feb; 16():53. PubMed ID: 26841870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER2 Overexpression and Amplification in Uterine Carcinosarcomas With Serous Morphology.
    Jenkins TM; Cantrell LA; Stoler MH; Mills AM
    Am J Surg Pathol; 2022 Apr; 46(4):435-442. PubMed ID: 35125452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esophageal Cancer Epigenomics and Integrome Analysis of Genome-Wide Methylation and Expression in High Risk Northeast Indian Population.
    Singh V; Singh LC; Vasudevan M; Chattopadhyay I; Borthakar BB; Rai AK; Phukan RK; Sharma J; Mahanta J; Kataki AC; Kapur S; Saxena S
    OMICS; 2015 Nov; 19(11):688-99. PubMed ID: 26496483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pan-cancer analysis of the two types of uterine cancer uncovered clinical and prognostic associations with m6A RNA methylation regulators.
    Zou Z; Zhou S; Liang G; Tang Z; Li K; Tan S; Zhang X; Zhu X
    Mol Omics; 2021 Jun; 17(3):438-453. PubMed ID: 34110327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition.
    Zhao S; Bellone S; Lopez S; Thakral D; Schwab C; English DP; Black J; Cocco E; Choi J; Zammataro L; Predolini F; Bonazzoli E; Bi M; Buza N; Hui P; Wong S; Abu-Khalaf M; Ravaggi A; Bignotti E; Bandiera E; Romani C; Todeschini P; Tassi R; Zanotti L; Odicino F; Pecorelli S; Donzelli C; Ardighieri L; Facchetti F; Falchetti M; Silasi DA; Ratner E; Azodi M; Schwartz PE; Mane S; Angioli R; Terranova C; Quick CM; Edraki B; Bilgüvar K; Lee M; Choi M; Stiegler AL; Boggon TJ; Schlessinger J; Lifton RP; Santin AD
    Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12238-12243. PubMed ID: 27791010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
    Zhu J; Wen H; Bi R; Wu X
    J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancers.
    Zhang B; Xing X; Li J; Lowdon RF; Zhou Y; Lin N; Zhang B; Sundaram V; Chiappinelli KB; Hagemann IS; Mutch DG; Goodfellow PJ; Wang T
    BMC Genomics; 2014 Oct; 15(1):868. PubMed ID: 25286960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic identification and annotation of human methylation marks based on bisulfite sequencing methylomes reveals distinct roles of cell type-specific hypomethylation in the regulation of cell identity genes.
    Liu H; Liu X; Zhang S; Lv J; Li S; Shang S; Jia S; Wei Y; Wang F; Su J; Wu Q; Zhang Y
    Nucleic Acids Res; 2016 Jan; 44(1):75-94. PubMed ID: 26635396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic signatures of familial cancer are characteristic of tumor type and family category.
    Joensuu EI; Abdel-Rahman WM; Ollikainen M; Ruosaari S; Knuutila S; Peltomäki P
    Cancer Res; 2008 Jun; 68(12):4597-605. PubMed ID: 18559504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.